Lack of Increased P15ink4b protein Expression in Basal Cell Carcinomas

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 12, 2012, Pages 6239-6244

  Moad, Ahmed Ismail Hassan ^a   Tan, Mei Lan ^a,b   Kaur, Gurjeet ^c   Mabruk, Mohamed ^d  

^a ADVANCED MEDICAL AND DENTAL INSTITUTE   (Malaysia)

^b Environment and Climate Change   (Malaysia)

^c INSTITUTE FOR RESEARCH IN MOLECULAR MEDICINE INFORMM   (Malaysia)

^d UNIVERSITI BRUNEI DARUSSALAM   (Brunei Darussalam)

Author keywords

Basal cell carcinoma; Immunohistichemistry; P15Ink4B

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2B;

ADULT; AGED; ARTICLE; BASAL CELL CARCINOMA; FEMALE; GENETICS; HUMAN; INFANT; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; SKIN; SKIN TUMOR; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, BASAL CELL; CYCLIN-DEPENDENT KINASE INHIBITOR P15; FEMALE; HUMANS; INFANT; MALE; MIDDLE AGED; SKIN; SKIN NEOPLASMS; YOUNG ADULT;

EID: 84877062737     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.12.6239     Document Type: Article

References (48)

1. American Cancer Society. Cancer Facts and Figures 2009. Atlanta, Ga: American Cancer Society.
2. Asuquo ME, Ngim O, Ugare G, Omotoso J, Ebughe G (2008). Major dermatologic malignancies encountered in a teaching hospital surgical department in South Nigeria. Am J Clin Dermatol, 9, 383-7.
3. Boukamp P (2005). UV-induced skin cancer: similarities-variations. J Dtsch Dermatol Ges, 3, 493.
4. Buljan M, Bulat V, Situm M, Mihić LL, Stanić-Duktaj S (2008). Variations in clinical presentation of basal cell carcinoma. Acta Clin Croat, 47, 25.
5. Dessinioti C, Tzannis K, Sypsa V, et al (2011). Epidemiologic risk factors of basal cell carcinoma development and age at onset in a Southern European population from Greece. Exp Dermatol, 20, 622-6.
6. D Nakamura Y, Ishitsuka Y, Ohara K, Otsuka F (2012). Basal cell carcinoma on the dorsum of the foot with inguinal and pelvic lymph nodes metastases. Int J Dermatol, 51, 1068-73.
7. Eissa S, Ali-Labib R, Khalifa A (2000). Deletion of p16 and p15 genes in schistosomiasis-associated bladder cancer (SABC). Clinica Chimica Acta, 300, 159.
8. Friedman RJ, Rigel DS, Berson DS, Rivers J (1991). Skin cancer: Basal cell and squamous cell carcinomas, Holleb AI, Fink DJ, Murphy GP, eds. American Cancer Society Textbook of Clinical Oncology, 290-305, The American Cancer Society, Inc. Atlanta.
9. Florenes VA, Bhattacharya N, Bani MR, et al (1996). TGF-beta mediated G1 arrest in a human melanoma cell line lacking p15INK4B: evidence for cooperation between p21Cip1/WAF1 and p27Kip1. Oncogene, 13, 2447.
10. Furonaka O, Takeshima Y, Awaya H, et al (2004). Aberrant methylation of p14(ARF), p15(INK4b) and p16(INK4a) genes and location of the primary site in pulmonary squamous cell carcinoma. Pathol Int, 54, 549.
11. Guo SX, Taki T, Ohnishi H, et al (2000). Hypermethylation of p16 and p15 genes and RB protein expression in acute leukemia. Leukemia Res, 24, 39.
12. Hartwell LH, Kastan MB (1994). Cell cycle control and cancer. Science, 266, 1821.
13. Hannon GJ, Beach D (1994). p15INK4B is potential effectors of TGF-beta-induced cell cycle arrest. Nature, 371, 257.
14. Hatta Y, Hirama T, Miller CW, et al (1995). Homozygous deletions of the p15(MTS2) and p16(CDKN2/MTS1) genes in adult T-cell leukemia. Blood, 85, 2699.
15. Hanahan D, Weinberg RA (2000). The hallmarks of cancer. Cell, 100, 57.
16. Jen J, Harper JW, Bigner SH, et al (1994). Deletion of p16 and p15 genes in brain tumors. Cancer Res, 54, 6353.
17. Jemal A, Devesa SS, Hartge P, Tucker MA (2001). Recent trends in cutaneous melanoma incidence among whites in the United States. J Natl Cancer Inst, 93, 678.
18. Jha AK, Nikbaht M, Jain V, Capalash N, Kaur J (2012). P16(INK4a) and p15(INK4b) gene promoter methylation in cervical cancer patients. Oncol Lett, 3, 1331-5
19. Kwa RE, Campana K, Moy RL (1992) Biology of cutaneous squamous cell carcinoma. J Am Acad Dermatol, 26, 1.
20. Kamb A, Gruis NA, Weaver-Feldhaus J, et al (1994). A cell cycle regulator potentially involved in genesis of many tumor types. Science, 264, 436.
21. Kricker A, Armstrong BK, English DR, Heenan PJ (1995). Does intermittent sun exposure cause basal cell carcinoma? A case-control study in Western Australia. Int J Cancer, 60, 489.
22. Karagas MR, McDonald JA, Greenberg ER, et al (1996). Risk of basal cell and squamous cell skin cancers after ionizing radiation therapy. For the skin cancer prevention study group. J Natl Cancer Inst, 88, 1848.
23. Kamb A (1998). Cyclin-dependent kinase inhibitors and human cancer. Curr Top Microbiol Immunol, 227, 139.
24. Kawakami T, Okamoto K, Ogawa O, Okada Y (2003). Multipoint methylation and expression analysis of tumor suppressor genes in human Renal cancer cells. Urology, 61, 226.
25. Li JM, Nichols MA, Chandrasekharan S, Xiong Y, Wang XF (1995). Transforming growth factor beat activates the promoter of cyclin- dependent kinase inhibitor p15INK4B through an Sp1 consensus site. J Biol Chem, 270, 26750.
26. Liu XQ, Zeng RS, Huang HZ, Liao GQ (2003). Expression of p15 and p16 proteins in tongue squamous cell carcinoma and their significances. Ai Zheng, 22, 1214.
27. Matanoski GM, Seltser R, Sartwell PE, Diamond EL, Elliott EA (1975). The current mortality rates of radiologists and other physician specialists: specific causes of death. Am J Epidemiol, 101, 199.
28. Miller SJ (1995). Etiology and pathogenesis of basal cell carcinoma. Clin Dermatol, 13, 527.
29. Musgrove EA, Lilischkis, Cornish Al, et al (1995). Expression of the cyclin-dependent kinase inhibitors p16INK4a, p15INK4b and p21WAF1/CIP1 in human breast cancer. Int J Cancer, 63, 584.
30. Moro A, Santos A, Morera-Diaz Y, Perea SE (2001). P27Kip1: Regulation and Function of a Cell Cycle Key Regulator. Biotecnologia Aplicada, 18, 193.
31. Moad AI, Tan ML, Kaur G, Hashim H, Mabruk MJ (2009). Immunohistochemical determination of the P15INK4b protein expression in cutaneous squamous cell carcinoma. J Cutan Pathol, 36, 183.
32. Naylor MF, Brown S, Quinlan C, Pitha JV, Evertt MA (1997). 9p21 Deletions in Primary Melanoma. Dermatology Online J, 3, 1.
33. Okamoto A, Hussain SP, Hagiwara K, et al (1995). Mutations in the p16INK4A/MTS1/CDKN2, p15INK4B/MTS2, and p18 genes in primary and metastatic lung cancer. Cancer Res, 55, 1448.
34. Quinn AG (1997). Ultraviolet radiation and skin carcinogenesis. Br J Hosp Med, 58, 261.
35. Reynisdottir I, Polyak K, Iavarone A, Massagué J (1995). Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta. Genes Dev, 9, 1831.
36. Robert AW (1996). How Cancer Arises. Sci Am, 275, 62.
37. Sandhu C, Garbe J, Bhattacharya N, et al (1997). Transforming growth factor beta stabilizes p15INK4B protein, increases p15INK4B-cdk4 complexes, and inhibits cyclin D1-cdk4 association in human mammary epithelial cells. Mol Cell Biol, 17, 2458.
38. Sangfelt O, Erickson S, Einhorn S, Grander D (1997). Induction of Cip/Kip and Ink4 cyclin dependent kinase inhibitors by interferon-alpha in hematopoietic cell lines. Oncogene, 14, 415.
39. Serrano M, Hannon GJ, Beach D (1993). A new regulatory motif in cell-cycle control causing specific inhibition of cyclin/CDK4. Nature, 366, 704.
40. Shintani S, Nakahara Y, Mihara M, Ueyama Y, Matsumura T (2001). Inactivation of the p14(ARF), p15(INK4B) and p16(INK4A) genes is a frequent event in human oral squamous cell carcinomas. Oral Oncol, 37, 498.
41. Sherr CJ (2001). The INK4a/ARF network in tumour suppression. Nat Reviews Mol Cell Biol, 2, 731.
42. Simić D, Situm M, Marijanović I, Hadzigrahić N (2011). Most common skin tumours in correlation with solar ultraviolet radiation in the area of West Herzegovina. Coll Antropol, 35, 1129-34.
43. Skellett AM, Hafiji J, Greenberg DC, Wright KA, Levell NJ (2012). The incidence of basal cell carcinoma in the under-30s in the UK. Clin Exp Dermatol, 37, 227-9
44. Takenouchi T (2006). Basal cell carcinoma. Gan To Kagaku Ryoho, 33, 1398.
45. Urosevic M, Dummer R (2002). Immunotherapy for nonmelanoma skin cancer: does it have a future? Cancer, 94, 477.
46. Uehara E, Takeuchi S, Yang Y, et al (2012). Aberrant methylation in promoter-associated CpG islands of multiple genes in chronic myelogenous leukemia blast crisis. Oncol Lett, 3, 190-2.
47. Viswanathan M, Tsuchida N, Shanmugam G (2003). Promoter hypermethylation profile of tumor-associated genes p16, p15, hMLH1, MGMT and E-cadherin in oral squamous cell carcinoma. Int J Cancer, 105, 41.
48. Wong TS, Man MW, Lam AK, et al (2003). The study of p16 and p15 gene methylation in head and neck squamous cell carcinoma and their quantitative evaluation in plasma by real-time PCR. Eur J Cancer, 39, 1881.